Measurement of hepatocyte growth factor in serum and plasma

International Journal of Clinical and Laboratory Research

Volumn 29, Issue 3, 1999, Pages 110-113

  Sakon, M ^a   Kita, Y ^a   Takeda, Y ^a   Higaki, N ^a   Ohzato, H ^a   Umeshita, K ^a   Hasuike, Y ^a   Gotoh, M ^a   Monden, M ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Blood sample; Hepatocyte growth factor; Leukocyte; Platelet

Indexed keywords

EID: 0032778147     PISSN: 09405437     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005990050073     Document Type: Article

References (23)

1. Zarnegar R, Michalopoulos GK. Purification and biological characterization of human hepatopoietin A, a peptide growth factor for hepatocytes. Cancer Res 1989; 49:3314.
2. Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 1991; 67:901.
3. Weidner MK, Arakaki N, Hartmann G, Vandekerckhove J, Weingart S, Rieder H, Fonatsch C, Tsubouchi H, Hishida T, Daikuhara Y, Birchmeier W. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci U S A 1991; 88:7001.
4. Selden C, Jones M, Wade D, Hodgson H. Hepatotropin mRNA expression in human foetal liver development and in liver regeneration. FEBS Lett 1990; 270:81.
5. Bussolino F, Di-Renzo MF, Ziehe M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, Comoglio PM. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992; 119:629.
6. Tsubouchi H, Niitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, Sakiyama O, Takahashi K, Kimoto M, Kawakami S, Setoguchi M, Tachikawa T, Shin S, Arima T, Daikuhara Y. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 1991; 13:1.
7. Tomiya T, Tani M, Yamada S, Hayashi S, Umeda N, Fujiwara K. Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients. Gastroenterology 1992; 103:1621.
8. Tomiya T, Nagoshi S, Fujiwara K. Significance of serum human hepatocyte growth factor levels in patients with hepatic failure. Hepatology 1992; 15:1.
9. Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T. Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology 1995; 21:106.
10. Lindroos PM, Zarnegar R, Michalopoulos GK. Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology 1991; 13:743.
11. Sakon M, Monden M, Gotoh M, Kanai T, Umeshita K, Mori T, Tsubouchi H, Daikuhara Y. Hepatocyte growth factor concentrations after liver resection. Lancet 1992; 339:818.
12. Russell WE, McGowan JA, Bucher NLR. Biological properties of a hepatocyte growth factor from rat platelets. J Cell Physiol 1984; 119:193.
13. Nakamura T, Nawa K, Ichihara A, Raise N, Nishino T. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett 1987; 224:311.
14. Nakamura T, Teramoto H, Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci U S A 1986; 83:6489.
15. Hara Y, Steiner M, Baldini MG. Characterization of the platelet-aggregating activity of tumor cells. Cancer Res 1980; 40: 1217.
16. 2 analogue, sodium beraprost, suppresses superoxide generation in human neutrophils by inhibiting p47 phox phosphorylation. Life Sci 1995; 57:1051.
17. Sakaguchi H, Seki S, Tsubouchi H, Daikuhara Y, Niitani Y, Kobayashi K. Ultrastructural location of human hepatocyte growth factor in human liver. Hepatology 1994; 19:1157.
18. Nishino T, Kaise N, Shindo Y, Nishino N, Nishida T, Yasuda S, Masui Y. Promyelocytic leukemia cell line, HL-60, produces human hepatocyte growth factor. Biochem Biophys Res Commun 1991; 181:323.
19. Inaba M, Koyama H, Hino M, Okuno S, Terada M, Nishizawa Y, Nishino T, Morii H. Regulation of release of hepatocyte growth factor from human promyelocytic leukemia cells, HL-60, by 1,25-dihydroxyvitamin D3, 12-O-tetradecanoylphorbol 13-acetate, and dibutyryl cyclic adenosine monophosphate. Blood 1993; 82:53.
20. Ertel W, Kremer JP, Kenney J, Steckholzer U, Jarrar D, Trentz O, Schildberg FW. Down regulation of proinflammatory cytokine release in whole blood from septic patients. Blood 1995; 85:1341.
21. Joseph S, MacDermot J. The N-terminal thrombin receptor fragment SFLLRN, but not catalytically inactive thrombin-derived agonists, activate U937 human monocytic cells: evidence for receptor hydrolysis in thrombin-dependent signalling. Biochem J 1993; 290:571.
22. Lynch JM, Henson PM. The intercellular retention of newly synthesized platelet-activating factor. J Immunol 1986; 137: 2653.
23. Hwang SB, Lee CSC, Cheah MJ, Shen TY. Specific receptor sites for 1-O-alkyl-2-acetyl-sn-glycero-3-phosphacholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes. Biochemistry 1983; 22:4756.